The Effect of Pro2 Modifications on the Structural and Pharmacological Properties of Endomorphin-2

被引:14
作者
Borics, Attila [1 ]
Mallareddy, Jayapal R. [1 ]
Timari, Istvan [2 ]
Koever, Katalin E. [2 ]
Keresztes, Attila [1 ]
Toth, Geza [1 ]
机构
[1] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary
[2] Univ Debrecen, Dept Chem, H-4010 Debrecen, Hungary
基金
匈牙利科学研究基金会;
关键词
MU-OPIOID RECEPTOR; NUCLEAR-MAGNETIC-RESONANCE; ALPHA-AMINO-ACIDS; CONFORMATIONAL-ANALYSIS; BIOACTIVE CONFORMATION; BIOLOGICAL-ACTIVITY; ANALOGS; AGONIST; PEPTIDES; PROLINE;
D O I
10.1021/jm300836n
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Endomorphins (EM-1 and EM-2) are selective, high affinity agonists of the mu-opioid (MOP) receptor, an important target in pain regulation. Their clinical use is impeded by their poor metabolic stability and limited entry to the central nervous system. In this study, the Pro(2) residue of EM-2 was modified systematically through substitution by hydroxyproline (Hyp), (S)-beta-homoproline beta Pro), 2-amino-cyclopentene-1-carboxylic acid (Delta Acpc), or 2-aminocyclohexene-1-carboxylic acid (Delta Achc) to obtain stable MOP active compounds. Both Hyp(2) and beta Pro(2) substitution decreased receptor affinity. Analogues incorporating alicyclic beta-amino acids exhibited diverse receptor binding properties, depending on the configuration of the substituent side-chain. (1S,2R)Delta Acpc(2)-EM-2 was shown to have MOP affinity and selectivity comparable to those of EM-2 and proved to act as agonist while being resistant to proteolysis. NMR and molecular dynamics (MD) studies revealed that bent backbone structures are predominant in the most potent analogues, while their presence is less pronounced in ligands of lower receptor affinity.
引用
收藏
页码:8418 / 8428
页数:11
相关论文
共 60 条
  • [1] Environmental mimic of receptor interaction: Conformational analysis of CCK-15 in solution
    Albrizio, S
    Carotenuto, A
    Fattorusso, C
    Moroder, L
    Picone, D
    Temussi, PA
    D'Ursi, A
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (04) : 762 - 769
  • [2] [Anonymous], 1986, NMR of proteins and nucleic acids
  • [3] BETA-TURN TOPOGRAPHY
    BALL, JB
    HUGHES, RA
    ALEWOOD, PF
    ANDREWS, PR
    [J]. TETRAHEDRON, 1993, 49 (17) : 3467 - 3478
  • [4] Opioid peptides: Synthesis and biological activity of new endomorphin analogues
    Biondi, Barbara
    Giannini, Elisa
    Negri, Lucia
    Melchiorri, Pietro
    Lattanzi, Roberta
    Rosso, Federica
    Ciocca, Luigi
    Rocchi, Raniero
    [J]. INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2006, 12 (02) : 145 - 151
  • [5] Structural comparison of μ-opioid receptor selective peptides confirmed four parameters of bioactivity
    Borics, Attila
    Toth, Geza
    [J]. JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2010, 28 (06) : 495 - 505
  • [6] Synthesis and opioid binding activity of dermorphin analogues containing cyclic beta-amino acids
    Bozu, B
    Fulop, F
    Toth, GK
    Toth, G
    Szucs, M
    [J]. NEUROPEPTIDES, 1997, 31 (04) : 367 - 372
  • [7] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [8] Endomorphin-1 analogues containing β-proline are μ-opioid receptor agonists and display enhanced enzymatic hydrolysis resistance
    Cardillo, G
    Gentilucci, L
    Qasem, AR
    Sgarzi, F
    Spampinato, S
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (12) : 2571 - 2578
  • [9] Case D.A., 2006, AMBER 9
  • [10] CASY AF, 1993, STERIC FACTOR MED CH